PPBT Purple Biotech Ltd
1.460USD-0.68%Mkt Cap: 2.38M $P/E: —1d ago
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humaniz…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Top Midday Gainers Purple Biotech (PPBT) said Wednesday that the US Patent and Trademark Office has issued a "Notice of | ||
 Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection Purple Biotech (NASDAQ:PPBT) has received a U. S. | ||